Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. | Director | Common Stock | 55K | $79.8K | $1.45 | May 29, 2024 | Direct |
SQZ Biotechnologies Co | Director | Stock Option | 39.9K | Jun 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 30, 2024 | Director |
SPRO | Spero Therapeutics, Inc. | Oct 5, 2023 | 1 | $0 | 4 | Oct 10, 2023 | Director |
SQZB | SQZ Biotechnologies Co | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
SPRO | Spero Therapeutics, Inc. | Jan 3, 2023 | 1 | $20K | 4 | Jan 5, 2023 | Director |
SPRO | Spero Therapeutics, Inc. | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director |
SQZB | SQZ Biotechnologies Co | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
SPRO | Spero Therapeutics, Inc. | Jan 5, 2022 | 1 | $20K | 4 | Jan 7, 2022 | Director |
SPRO | Spero Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
SQZB | SQZ Biotechnologies Co | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
SQZB | SQZ Biotechnologies Co | Jul 1, 2021 | 0 | $0 | 3 | Jul 1, 2021 | Director |